Align Technology, Inc.
ALGN Healthcare Medical Instruments & Supplies
Align Technology, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, up 0.90% from fiscal 2024.
- Revenue
- +1.92%
- EPS
- +143.9%
- Free cash flow
- +8.26%
Quarter to September 2026, against a year earlier
Follow ALGN
Alert me
Align Technology, Inc. (ALGN) P/E ratio
As of 5 November 2026, Align Technology, Inc. (ALGN) trades at a P/E ratio of 23.1×. Over the past ten years it has ranged from 6.3× (April 2020) to 115× (June 2018); the current reading is higher than 8% of that period. That is below the Medical Instruments & Supplies industry median of 30.3× and below the Healthcare sector median of 25.2×.
P/E ratio, daily
Embed this chart
Annual newest first
| Period | P/E ratio | Change |
|---|---|---|
| FY2025 | 27.6× | (25.64%) |
| FY2024 | 37.1× | (19.57%) |
| FY2023 | 46.1× | 0.39% |
| FY2022 | 45.9× | (31.62%) |
| FY2021 | 67.2× | 184.06% |
| FY2020 | 23.7× | (52.78%) |
| FY2019 | 50.1× | 19.60% |
| FY2018 | 41.9× | (46.11%) |
| FY2017 | 77.7× | 90.78% |
| FY2016 | 40.7× | 11.36% |
Quarterly newest first
| Period | P/E ratio | Change |
|---|---|---|
| Sep 2026 | 21.1× | (27.87%) |
| Jun 2026 | 29.3× | 1.97% |
| Mar 2026 | 28.7× | 4.08% |
| Dec 2025 | 27.6× | 13.68% |
| 43 more quarters | Free account |
Against its own ten years
P/E ratio against peers
| Company | P/E ratio |
|---|---|
| RGEN Repligen Corporation compare | n/m |
| BAX Baxter International Inc. compare | n/m |
| BLCO Bausch + Lomb Corporation compare | n/m |
| TFX Teleflex Incorporated compare | n/m |
| COO The Cooper Companies, Inc. compare | 21.7× |
| ALGN Align Technology, Inc. | 23.1× |
| AVTR Avantor, Inc. compare | 30.3× |
| ATR AptarGroup, Inc. compare | 34.6× |
| SOLV Solventum Corporation compare | 97.3× |
| Medical Instruments & Supplies industry median | 30.3× |
| Healthcare sector median | 25.2× |
| Market median | 17.9× |
What P/E ratio is
Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.
Stock Price ÷ EPS (Basic) (TTM)
More on ALGN
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement